| |
| Issue |
Title |
| |
| No 3 (2023) |
Сardioprotective agents with biaromatic structure. Part 6. Beta blockers |
Abstract
PDF (Rus)
|
|
G. V. Mokrov |
| |
| No 2 (2023) |
Сardioprotective agents with biaromatic structure. Part 5. Potassium Kv1.5-channels blockers |
Abstract
PDF (Rus)
|
|
G. V. Mokrov |
| |
| No 1 (2023) |
Application of variance analysis in experimental pharmacology |
Abstract
PDF (Rus)
|
|
I. B. Tsorin |
| |
| No 4 (2022) |
Сardioprotective agents with biaromatic structure. Part 4. Potassium hERG channels blockers and modulators |
Abstract
PDF (Rus)
|
|
G. V. Mokrov |
| |
| No 3 (2022) |
Сardioprotective agents with biaromatic structure. Part 3. Sodium channel blockers |
Abstract
PDF (Rus)
|
|
G. V. Mokrov |
| |
| No 2 (2022) |
Сardioprotective agents with biaromatic structure. Part 2. HCN channel blockers |
Abstract
PDF (Rus)
|
|
G. V. Mokrov |
| |
| No 4 (2021) |
Novel glyproline GZK-111 with neuropsychotropic activity |
Abstract
PDF (Rus)
|
|
K. N. Koliasnikova, A. G. Alyaeva, E. A. Kuznetsova |
| |
| No 4 (2021) |
Сardioprotective agents with biaromatic structure. Part 1. Calcium channel blockers |
Abstract
PDF (Rus)
|
|
G. V. Mokrov |
| |
| No 1 (2012) |
Биотрансформация и фармакокинетика морфолинсодержащих лекарственных препаратов |
Abstract
PDF (Rus)
|
|
, , |
| |
| No 1 (2012) |
Биотрансформация и фармакокинетика производных адамантана |
Abstract
PDF (Rus)
|
|
, , |
| |
| No 1 (2012) |
Система цитохрома Р450 в лёгких: роль в патогенезе заболеваний и фармакокинетике лекарственных средств |
Abstract
PDF (Rus)
|
|
, , , , |
| |
| No 2 (2012) |
Основные механизмы доставки лекарственных веществ в мозг с помощью полимерных наночастиц |
Abstract
PDF (Rus)
|
|
, |
| |
| No 1 (2014) |
Isoform CYP1A2, as a part of the cytochrome P450 superfamily |
Abstract
PDF (Rus)
|
|
Y. G. Novickaya, V. P. Zherdev, A. O. Viglinskaya, A. A. Litvin |
| |
| No 1 (2014) |
Role of lectins as biologically active substances in pharmaceutical preparations |
Abstract
PDF (Rus)
|
|
V. A. Antonyuk |
| |
| No 1 (2015) |
Review of existing methodologies to assess the activity of CYP2D6 using exogenous and endogenous markers |
Abstract
PDF (Rus)
|
|
A. D. Abdrashitov, G. N. Gildeeva, G. V. Ramenskaya, V. V. Smirnov |
| |
| No 1 (2015) |
Biosimilars - drugs of the future |
Abstract
PDF (Rus)
|
|
E. A. Eltcova, G. V. Ramenskaya, E. A. Smolyarchuk, A. V. Bushmanova |
| |
| No 1 (2015) |
Current trends in the standardization of preparations of allergens |
Abstract
PDF (Rus)
|
|
A. A. Ignatov, G. V. Ramenskaya, V. V. Smirnov |
| |
| 1 - 17 of 17 Items |
|
